Trials / Completed
CompletedNCT00662857
A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro
A Phase 2, Open-Label, Randomized, 2-Way Crossover, Clinical Trial to Compare the Pharmacokinetics of 2 Formulations of "Intended Commercial Product" Technosphere® Insulin Inhalation Powder and to Determine the Bioavailability of a 30 Unit Cartridge of "Intended Commercial Product" Technosphere® Insulin Inhalation Powder Versus a 10 Unit Subcutaneous Injection of Insulin Lispro in Subjects With Type 1 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Mannkind Corporation · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
28 subjects to be enrolled for a screening period, 3 dosing visits \& a follow-up visit. Visits 2 and 3 dosing of TI Inhalation Powder, cross over between two 15 U cartridges and one 30 U cartridge. Visit 4 dosing will be a sc injection of 10 IU of RAA (rapid-acting insulin analogue).
Detailed description
28 eligible subjects were planned to be enrolled to determine bioequivalence and safety parameters of two 15 U TI Inhalation Powder cartridges versus one 30 U TI Inhalation Powder cartridge, according to a randomized, 2-way crossover design. Additionally, bioavailability of one 30 U TI Inhalation Powder cartridge to a single subcutaneous injection of 10 IU of RAA will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Technosphere® Insulin Inhalation Powder | TI Inhalation Powder, two 15 U cartridges |
| DRUG | Technosphere Insulin® Inhalation Powder | TI Inhalation Powder, one 30 U cartridge |
| DRUG | RAA Population | RAA Population: All subjects received a single 10 IU sc injection of insulin lispro. |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-11-01
- Completion
- 2008-12-01
- First posted
- 2008-04-21
- Last updated
- 2014-10-16
- Results posted
- 2014-10-16
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00662857. Inclusion in this directory is not an endorsement.